Infectious disease billing hinges on the infusion administration hierarchy 96365-96368, antimicrobial J-code capture, and HIV E/M with opportunistic infection sequencing. Add modifier 25 when infusion and E/M happen on the same day, plus OPPS facility billing for hospital outpatient infusion, and general billers miss revenue on every encounter. MedFactor delivers infectious-disease-specific RCM that protects every claim.
From HIV longitudinal management to outpatient antimicrobial infusion and travel medicine, we tailor billing to the coding rules of every infectious disease subspecialty.
HIV E/M 99202-99215, B20 sequencing, opportunistic infection coding (B37 candidiasis, Z20 contact/exposure), and antiretroviral coordination.
Consults and inpatient ID follow-up with sepsis (A40-A41), bacteremia, and complex E/M medical-necessity documentation.
Outpatient IV antimicrobial infusion 96365/96366/96367/96368 hierarchy with J-code capture (J0696, J0878, J3373, J2543) and JW wastage.
Pre-travel consults, vaccine administration, malaria prophylaxis, and tropical infection diagnosis coding with travel-specific Z codes.
Surgical site and osteomyelitis management, IV-to-oral antimicrobial conversion, and long-term drug therapy Z79 tracking.
Opportunistic infection sequencing (B20 + secondary), candidiasis, viral hepatitis B19, and prophylactic antimicrobial capture.
Infectious disease revenue lives or dies on the non-chemo infusion ladder 96365-96368, the antimicrobial J-code billed on a separate line, and modifier 25 when an E/M is performed with the infusion. Get any of these wrong and the entire encounter is denied. This is the largest source of ID revenue leakage.
One infusion session uses 96365 as the base first-hour code, 96366 for each additional hour, 96367/96368 for sequential drugs, and the antimicrobial billed by HCPCS J-code on its own line. A same-day E/M requires modifier 25 to avoid bundling into the infusion admin code.
ID billing is governed by the infusion administration hierarchy, antimicrobial J-code capture, and modifier 25 rules that general billing companies cannot navigate effectively.
The 96360-96368 ladder is mis-sequenced — 96367/96368 for sequential drugs dropped, or 96365 incorrectly used for hydration (96360/96361), losing admin revenue.
Antimicrobials not billed by their HCPCS J-code (J0696 ceftriaxone, J3373 vancomycin, J0878 daptomycin), or billing units miscalculated against the per-mg descriptor.
Same-day E/M denied as bundled into the infusion admin code when modifier 25 is not appended with documented distinct medical necessity.
B20 HIV sequenced incorrectly with opportunistic infection codes; E/M level unsupported by documentation for chronic HIV management.
Hospital outpatient infusion under OPPS billed with professional fee logic instead of APC packaging rules, triggering facility denials.
Long-acting antimicrobials (e.g., oritavancin, dalbavancin) denied for missing prior authorization or step-therapy documentation.
Quick reference for the most frequently used codes in infectious disease billing and coding. Codes reflect the current code sets and are subject to annual updates — always verify against the current-year fee schedule before submission.
| Code | Description | Common Use |
|---|---|---|
| 96360 | IV hydration, first 31 min | Hydration base (non-therapeutic) |
| 96361 | IV hydration, each addl 31 min | Hydration add-on |
| 96365 | IV infusion, therapeutic, first hr (non-chemo) | Antimicrobial infusion base |
| 96366 | IV infusion, each addl hour | Additional infusion time |
| 96367 | IV infusion, sequential drug, first hr | New antimicrobial same visit |
| 96368 | IV infusion, sequential addl hour | Sequential drug addl time |
| 96372 | Therapeutic IM/SC injection | Antimicrobial injection admin |
| 99202-99215 | Office E/M (new & established) | HIV management / ID consult |
| J0696 | Ceftriaxone sodium, per 250 mg | Common IV antimicrobial |
| J3373 | Vancomycin HCl, per 10 mg (replaced J3370 Jul 2025) | MRSA / serious Gram-positive |
| J0878 | Daptomycin, per 1 mg | MRSA bacteremia / cSSSI |
| J0133 | Acyclovir, per 5 mg | HSV / VZV in immunocompromised |
| J0295 | Ampicillin/sulbactam, per 1.5 gm | Polymicrobial / aspiration |
| J2543 | Piperacillin/tazobactam, per 1.125 gm | Broad-spectrum IV antibiotic |
| J0692 | Cefepime HCl, per 500 mg | Broad-spectrum cephalosporin |
| Code | Description | Clinical Context |
|---|---|---|
| B20 | HIV disease | HIV management E/M primary |
| B19.x | Viral hepatitis | Chronic hepatitis management |
| A40.x | Streptococcus sepsis | Sepsis / bacteremia |
| A41.x | Sepsis, other | Sepsis / bacteremia |
| A49.x | Bacterial infection, unspecified site | Empiric antimicrobial therapy |
| B37.x | Candidiasis | Opportunistic fungal infection |
| J00-J06 | Acute respiratory infections | URI / antimicrobial indication |
| Z79.x | Long-term (chronic) drug use | Long-term antimicrobial therapy |
| Z11.x | Encounter for screening | HIV / infection screening |
| Z20.x | Contact/exposure | Exposure to communicable disease |
| Modifier | Description | ID Application |
|---|---|---|
| 25 | Separate E/M same day | E/M with same-day infusion / injection |
| 59 | Distinct procedural service | Distinct services same session |
| 51 | Multiple procedures | Multiple procedures same session |
| 22 | Increased procedural service | Unusually complex infusion / procedure |
| 52 | Reduced services | Partial infusion / reduced service |
| JW | Discarded drug waste | Single-dose vial antimicrobial wastage |
| 95 | Synchronous telemedicine | HIV / ID telehealth follow-up |
| GT | Telehealth (legacy payer) | Telehealth for select commercial payers |
Comprehensive revenue cycle management designed specifically for infectious disease practices.
Specialty coders handle the 96365-96368 infusion ladder, antimicrobial J-code capture, HIV E/M, and OPPS facility billing with accuracy.
Infusion hierarchy defense, modifier 25 E/M appeals, J-code capture corrections, and OPPS facility denial resolution with documentation.
Pre-treatment authorization for long-acting antimicrobials (oritavancin, dalbavancin), specialty antivirals, and infusion therapy.
Prioritized follow-up on aged infusion, antimicrobial, and HIV claims with strategic payer escalation to maximize recovery.
Regular audits focused on infusion admin hierarchy, modifier 25/JW, HIV diagnosis sequencing, and OPPS packaging rules.
Real-time dashboards tracking infusion admin capture, antimicrobial J-code utilization, and HIV management E/M levels.
Understanding the most common denial reasons is the first step to preventing them on infusion, antimicrobial, and HIV claims.
Sequential infusion (96367/96368) dropped, or hydration 96360/96361 incorrectly billed as therapeutic 96365/96366.
Correct ladder sequencing 96365 base, 96366 addl hr, 96367/96368 sequential, with hydration separated.
Drug not billed by HCPCS J-code, or billing units miscalculated against the per-mg/per-gram descriptor.
J-code per antimicrobial (J0696, J3373, J0878, J2543) with correct unit calculation and JW wastage.
Same-day E/M denied as bundled into the infusion admin code when modifier 25 is missing or unsupported.
Modifier 25 with documented distinct medical necessity for the E/M beyond infusion management.
Hospital outpatient infusion billed with professional-fee logic instead of APC packaging rules under OPPS.
OPPS-aware facility billing with APC packaging, separately payable drug and admin logic.
Identifying and plugging these common revenue leakage points can significantly improve your practice's bottom line.
96367/96368 not billed for additional antimicrobials in the same visit.
Billing units wrong vs. per-mg J-code descriptor (e.g., J3373 per 10 mg).
Same-day E/M lost when modifier 25 not applied with distinct necessity.
Discarded single-dose antimicrobial not billed with modifier JW.
See how infectious-disease-specific revenue cycle management transforms your practice's financial performance.
A structured onboarding process designed to deliver measurable improvements within the first 90 days.
Review of ID billing operations, infusion admin capture, J-code utilization, and revenue cycle baseline.
EMR and infusion-system integration, dedicated ID billing team, and payer enrollment verification.
Full billing with real-time claim submission, modifier verification, and denial prevention protocols.
Performance review against baseline, workflow optimization, and documented revenue improvement.
How our infectious-disease-specific approach compares to in-house billing and general medical billing companies.
| Capability | In-House Team | General Billing Co. | MedFactor ID |
|---|---|---|---|
| Infusion admin 96365-96368 hierarchy | Inconsistent | ✕ | ✓ |
| Antimicrobial J-code capture | Inconsistent | ✕ | ✓ |
| Modifier 25 with infusion + E/M | ✕ | ✕ | ✓ |
| HIV E/M + opportunistic infection sequencing | ✕ | Partial | ✓ |
| OPPS / facility infusion billing | ✕ | Partial | ✓ |
| JW wastage modifier capture | Manual | Partial | ✓ |
| Long-acting antimicrobial prior auth | Manual | Partial | ✓ |
| Infusion & J-code utilization reporting | ✕ | ✕ | ✓ |
| Dedicated ID billing team | ✕ | ✕ | ✓ |
Our team combines deep infectious disease billing expertise with the technology and processes to deliver consistent, measurable results for HIV, infusion, and antimicrobial practices.
Discover exactly where your ID practice is losing revenue. Our no-obligation audit analyzes your infusion admin hierarchy, antimicrobial J-code capture, and modifier 25 compliance.
Real results from ID practices that partnered with MedFactor for specialty revenue cycle management.
An HIV clinic was under-documenting E/M levels and sequencing B20 incorrectly with opportunistic infection codes. MedFactor implemented level-appropriate E/M documentation and correct B20 sequencing, recovering substantial chronic-care revenue in eight months.
An outpatient antimicrobial infusion center was dropping sequential infusion codes 96367/96368 and miscalculating J-code units. MedFactor implemented the full infusion ladder and J-code unit verification, recovering admin and drug revenue.
A hospital-based ID consult group was billing outpatient infusion with professional-fee logic instead of OPPS APC packaging. MedFactor implemented OPPS-aware facility billing, recovering packaged and separately payable drug revenue.
No matter where your infectious disease practice operates, our team understands the payer landscape and regulatory requirements in your region.
Deep coding knowledge across Medicare, Medicaid, and commercial payers for ID services and infusion.
Hospital outpatient infusion packaging rules applied correctly across all 50 states.
Ryan White, ADAP, and Medicaid HIV program billing rules applied in every state.
Telehealth coverage and modifier 95/GT rules for HIV and ID follow-up across state lines.
Common questions from ID practices considering MedFactor's specialty RCM services.
Non-chemo infusion administration follows a defined ladder. Hydration is billed with 96360 (first 31 minutes) and 96361 (each additional 31 minutes). Therapeutic, prophylactic, or diagnostic IV infusions use 96365 (first hour) as the base, 96366 for each additional hour of the same infusion, 96367 for a sequential drug's first hour, and 96368 for each additional hour of that sequential drug. Therapeutic IM or subcutaneous injections use 96372. The initial infusion admin code (96365) is the base; subsequent drugs in the same session bill as sequential (96367/96368), not as additional 96365s. We sequence the ladder correctly so every payable admin increment is captured rather than dropped or rebundled.
The antimicrobial drug is billed on its own claim line by HCPCS J-code, separate from the infusion admin code. Billing units equal the dose administered divided by the J-code descriptor — for example J0696 (ceftriaxone sodium, per 250 mg) for a 1 g dose is 4 units; J3373 (vancomycin HCl, per 10 mg, which replaced deleted J3370 in July 2025) for a 1,000 mg dose is 100 units; J0878 (daptomycin, per 1 mg) for a 500 mg dose is 500 units. We verify the descriptor, calculate units precisely, and append modifier JW for discarded single-dose vial wastage where the payer allows, so drug revenue is not lost to descriptor errors or missing wastage reporting.
When a separately identifiable evaluation and management service is performed on the same day as an infusion or injection administration, the E/M is billed with modifier 25 appended. The E/M documentation must show a distinct reason for the visit beyond the routine work of starting and monitoring the infusion — for example, a new complaint, a change in treatment plan, or a separate condition evaluated. Without modifier 25, the E/M is denied as bundled into the infusion admin code. We pair modifier 25 with documented distinct medical necessity on every same-day E/M so the evaluation is paid rather than bundled into the infusion.
B20 (HIV disease) is the code that classifies the patient as having HIV; once a patient has had an HIV-related diagnosis, B20 is sequenced and subsequent visits continue to use B20 rather than re-assigning a different HIV code. When an opportunistic infection is present (for example B37 candidiasis, or a specific pneumonia), the opportunistic infection is coded as an additional diagnosis and sequenced per ICD-10 guidelines; B20 remains the HIV code. E/M level (99202-99215) is supported by documentation of chronic condition management, complexity, and risk. We ensure B20 sequencing is consistent, opportunistic infections are added with correct sequencing, and E/M documentation supports the level billed.
When infusion is performed in a hospital outpatient department, billing falls under the Outpatient Prospective Payment System (OPPS), not the physician fee schedule. Under OPPS, most services are packaged into Ambulatory Payment Classifications (APCs), and many drugs and admin services are packaged into the primary APC rather than separately payable. Separately payable drugs (typically those above a cost threshold) and certain administration codes may bill separately, with specific OPPS packaging rules. Billing OPPS with professional-fee logic causes denials. We apply OPPS-aware packaging rules on hospital outpatient infusion claims so facility revenue is captured per APC logic and separately payable components are billed correctly.
Long-acting antimicrobials such as oritavancin and dalbavancin frequently require prior authorization and may be subject to step-therapy requirements that favor conventional IV therapy first. We obtain pre-administration authorization, document medical necessity for the long-acting agent (such as outpatient suitability, adherence risk, or completion-of-therapy concerns), and capture the J-code with correct units and modifier JW where applicable. Pre-authorization before administration prevents the most common denial on these high-cost agents and preserves the drug plus admin revenue for the encounter.
MedFactor applies the same code-level precision across the full practice spectrum. See how we bill these related specialties.
CPT®, ICD-10, HCPCS, and modifier codes referenced on this page reflect the current code sets and are subject to annual updates — always verify against the current-year fee schedule before submission. KPIs and case-study figures shown are representative benchmarks, not guarantees of individual practice results.
Your ID practice deserves billing partners who know the 96365-96368 infusion ladder, antimicrobial J-code capture, HIV E/M sequencing, and OPPS facility rules — and code every claim correctly. Let MedFactor show you what specialty RCM can do.